Stryker stroke treatment wows in TREVO 2 trial; LabCorp and XDx to develop diagnostic for lupus flares;

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

 @FierceMedDev: HeartWare gained expanded European approval for its HVAD implant. Trials continue in the U.S., however. Story | Follow @FierceMedDev

> Stryker's ($SYK) Trevo Retriever system to treat acute strokes generated "significantly better" post-device revascularization than a predecessor device, based on results from the company's TREVO 2 clinical trial. Release

> LabCorp ($LH) is joining forces with XDx to develop a diagnostic for lupus flares, or when the autoimmune disease acts up. Story

> Many pregnant women aren't being screened for chlamydia and gonorrhea, as per CDC recommendations, according to a new study by Quest Diagnostics ($DGX) and Rutgers University. Release

> SPR Therapeutics, a neurostimulation pain-relief device company, nailed down a $900,000 loan from the state of Ohio to help the company ramp up production of its signature product. Story

> The Michigan Medical Device Accelerator program won a $400,000 grant from the W.K. Kellogg Foundation. Plans call for using the money to fuel continue fueling more device company startups. Story

> Aerocrine in Sweden gained regulatory approval to market its Niox Mino airway inflammation monitor and test kit in Australia. Both products are meant for asthma patients. Release

Pharma News

 @FiercePharma: Another German drugmaker in takeover talks: Riemser may pick shortlist by next week--BloombergStory | Follow @FiercePharma

> New Teva chief slashes sales forecast by $1B. News

> EU antitrust officials probe parallel trade. Article

> Securities watchdogs reportedly probe Shanghai Pharma deals. Item

> FDA panel draws blood in Xarelto's bid for new use. Report

Biotech News

 @FierceBiotech: Vitamin D boosts TB shot as cancer therapy. More | Follow @FierceBiotech

 @RyanMFierce: Pfizer brings Lipitor brand to mobile app stores. Report | Follow @RyanMFierce

 @JohnCFierce: So Globe's verastem coverage says best-case scenario is start trials in a year, products available in four. A three-year cancer stem cell program? Ha. | Follow @JohnCFierce

> J&J loses key FDA panel vote on Xarelto. Item

> European pharmas join forces on $285M antibiotics collaboration. News

> Sanofi chief highlights high hopes for liver cancer drug. Story

> Upstart biotech lures Vertex founder out of retirement. Report

Pharma Manufacturing News

 @EricPFierce: FDA to Crescendo: We told you so. Marshals seize steroid gel from California firm that was selling unapproved drug. Report | Follow @EricPFierce

> FDA may impose more QA checks on heparin makers. Story

> Recipharm snags $114 million loan, says its shopping. Article

> Heart attack test alert from Alere. More

> FDA takes aim at Spanish drugmaker. Item

CRO News

 @NesaNFierce: What should a CDMO do with 90 million Euros? Buy more CDMOs, as Recipharm announced it will do. Article | Follow @NesaNFierce

> SGS picks up testing company Vitrology for an undisclosed fee. News

> Pfizer's David Simmons joins PPD as new CEO and chairman. Story

> PRA expands European ops with new Dutch and British offices. More

> Quintiles survey shows U.S. and U.K. payers want to improve R&D with increased involvement. Item

Vaccines News

> Wishing you a happy HIV Vaccine Awareness Day. Report

> Vitamin D boosts TB shot as cancer therapy. Article

> DNA vaccine swats TB and HIV. News

> HIV vaccine carries its own adjuvant into clinical trials. Story

And Finally... Dynasil Corporation of America ($DYSL) and the Mayo Clinic will jointly develop therapeutic hypothermia core cooling technology that would protect the brain during cardiac arrest and traumatic brain injury. Release